FERRAROTTI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.188
EU - Europa 770
AS - Asia 544
AF - Africa 2
SA - Sud America 2
Totale 2.506
Nazione #
US - Stati Uniti d'America 1.181
CN - Cina 465
IE - Irlanda 256
IT - Italia 111
UA - Ucraina 96
FI - Finlandia 88
DE - Germania 85
SG - Singapore 67
SE - Svezia 47
GB - Regno Unito 41
BE - Belgio 12
FR - Francia 12
CA - Canada 7
CZ - Repubblica Ceca 4
DK - Danimarca 4
HK - Hong Kong 4
RU - Federazione Russa 4
NL - Olanda 3
AT - Austria 2
CH - Svizzera 2
MU - Mauritius 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BR - Brasile 1
ES - Italia 1
HU - Ungheria 1
IN - India 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
PH - Filippine 1
TH - Thailandia 1
VN - Vietnam 1
Totale 2.506
Città #
Dublin 256
Chandler 244
Nanjing 106
Jacksonville 99
Ashburn 92
Boardman 84
Ann Arbor 78
Beijing 70
Helsinki 52
Singapore 49
Lawrence 45
Princeton 45
Medford 44
Nanchang 42
Dearborn 40
Wilmington 34
Shenyang 31
Changsha 29
New York 29
Shanghai 29
Houston 24
Jiaxing 23
Hebei 22
Pavia 18
Vinnytsia 17
Tianjin 15
Hangzhou 14
Piemonte 14
Woodbridge 14
Brussels 12
Montesilvano Marina 12
Rome 11
Redwood City 10
Washington 10
Kunming 9
Dallas 8
Norwalk 8
Los Angeles 7
Chicago 6
Fairfield 6
Hefei 6
Jinan 6
Milan 6
Munich 6
Des Moines 5
Toronto 5
Brno 4
Canyon Country 4
Frankfurt am Main 4
Hårlev 4
Padova 4
Seattle 4
Fort Worth 3
Nuremberg 3
Taizhou 3
Tappahannock 3
Zhengzhou 3
Amsterdam 2
Basel 2
Berlin 2
Cernusco sul Naviglio 2
Changchun 2
Chengdu 2
Cornigliano 2
Francavilla al Mare 2
Guidonia 2
Ningbo 2
Orange 2
Phoenix 2
Piscataway 2
San Jose 2
Turin 2
Abbiategrasso 1
Anqing 1
Auburn Hills 1
Bangkok 1
Borås 1
Brockton 1
Chongqing 1
Dubai 1
Düsseldorf 1
Edmond 1
Esslingen am Neckar 1
Florence 1
Fuzhou 1
Gallarate 1
Guangzhou 1
Haikou 1
Lanzhou 1
Linyi 1
London 1
Madrid 1
Monmouth Junction 1
Montreal 1
Nanning 1
Novara 1
Perugia 1
Putian 1
Quezon City 1
Radeberg 1
Totale 1.889
Nome #
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 122
Lyosecretome for use in the treatment of autoimmune diseases 82
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 81
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 75
α₁-Antitrypsin level and pheno/genotypes 73
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 72
Identification and characterisation of eight novel SERPINA1 null mutations. 72
Expression of receptor for advanced glycation end products in sarcoid granulomas. 69
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 67
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 63
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 63
A regulatory SNP in the Promoter Region of the RAGE Gene 62
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 61
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 60
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 57
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 57
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 56
COPD: no gene left unturned 56
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 56
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 56
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 55
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 55
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 55
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 53
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 52
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 52
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 52
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 50
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 50
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency 50
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 46
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. 46
Update on α1-antitrypsin deficiency 40
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 39
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization. 38
Alpha-1 antitrypsin deficiency: From the lung to the heart? 38
Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: Enough is enough 35
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 32
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 30
α1-Antitrypsin deficiency. 29
Immune Activation in alpha(1)-Antitrypsin-Deficiency Emphysema Beyond the Protease-Antiprotease Paradigm 27
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 26
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. 24
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. 22
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. 21
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 20
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 19
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency 15
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithms 12
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review 11
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency 11
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency 11
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 11
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 9
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature 8
Recommendations for the measurement of the most important plasma proteins 7
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 6
Improving the diagnosis of AATD with aid of serum protein electrophoresis: A prospective, multicentre, validation study 5
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 5
Long-term effect of α1-antitrypsin augmentation therapy on the decline of fev1 in deficient patients: An analysis of the air database 4
What is the knowledge on alpha-1 antitrypsin deficiency among Italian pulmonologists? 4
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 4
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 4
Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients 4
Complement receptor 1 gene polymorphisms in sarcoidosis. 4
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 4
Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants 3
Protocol for the earco registry: A pan-european observational study in patients with α1-antitrypsin deficiency 3
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology 3
Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency 3
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 3
Research priorities in α1-antitrypsin deficiency: Results of a patients’ and healthcare providers’ international survey from the earco clinical research collaboration 2
Sanger and Next-Generation Sequencing of AAT 2
Place of genotyping and phenotype in addition to the assay of serum α -1 antitrypsin 2
Alpha-1 antitrypsin screening in a selected cohort of patients affected by chronic pulmonary diseases in Naples, Italy 2
The importance of n186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 2
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants 2
PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency 2
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 2
How can we improve the detection of Alpha1-antitrypsin deficiency? 2
Diagnosis and treatment of pulmonarydisease in alfa-1-antitrypsin deficiency: A statement of European Respiratory Society 2
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 2
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 2
Air Trapping Is Associated with Heterozygosity for Alpha-1 Antitrypsin Mutations in Patients with Asthma 2
New patient-centric approaches to the management of alpha-1 antitrypsin deficiency 2
SERPINA1 gene variants in individuals from the general population with reduced ?1-antitrypsin concentrations 2
Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy 1
Totale 2.601
Categoria #
all - tutte 11.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020189 0 0 0 0 12 40 13 36 16 37 31 4
2020/2021266 24 16 12 17 9 28 14 47 13 33 29 24
2021/2022199 6 2 4 5 1 2 5 16 13 4 28 113
2022/2023712 85 49 6 44 82 68 3 30 308 7 20 10
2023/2024395 26 75 16 10 35 98 11 20 2 53 27 22
2024/2025277 20 71 76 90 20 0 0 0 0 0 0 0
Totale 2.601